Cardiac troponin I (cTnI) is measured through a simple blood test. A healthcare provider draws a blood sample, which is then analyzed in a lab to measure the amount of this protein present.
In the context of amyloidosis staging, the key threshold to know is:
- Normal: cTnI below 0.1 nanograms per milliliter
- Elevated Show Full Answer
Cardiac troponin I (cTnI) is measured through a simple blood test. A healthcare provider draws a blood sample, which is then analyzed in a lab to measure the amount of this protein present.
In the context of amyloidosis staging, the key threshold to know is:
- Normal: cTnI below 0.1 nanograms per milliliter
- Elevated: cTnI at or above 0.1 nanograms per milliliter
Elevated cTnI can indicate heart muscle cell damage, which helps doctors understand how amyloidosis may be affecting the heart. This test is often used alongside a BNP (brain natriuretic peptide) blood test as part of cardiac staging for amyloidosis — particularly when a hospital isn't equipped to test for NT-proBNP.
It's always best to ask the care team to walk through what the results mean for a specific situation, as staging is just one piece of the bigger picture.
June 7
Join
Your Privacy Choices
